Leaflet Modification to Mitigate Coronary Obstruction Risk During TAVR
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Occhipinti G.
- Laudani C.
- Jabri A.
- Pensotti F.
- Leone P.P.
- Khokhar A.A.
- Genereux P.
- Beneduce A.
- Wongpraparut N.
- Mangieri A.
- Serra V.
- Nombela-Franco L.
- Asmarats L.
- Teles R.C.
- Chandavimol M.
- Romaguera R.
- Akodad M.
- Cuisset T.
- Tayal R.
- Algethami A.R.
- Díaz J.F.
- Laffond A.
- Martin P.
- Perez L.
- Ruiz-Quevedo V.
- Sarno G.
- Vázquez Álvarez M.E.
- Assafin M.
- García-Gómez M.
- Ruberti A.
- Sanchis L.
- Freixa X.
- Maisano F.
- Buzzatti N.
- Giustino G.
- De Backer O.
- Latib A.
- Amat-Santos I.J.
- Villablanca P.A.
- Regueiro A.
Grupos
Abstract
Background Coronary obstruction (CO) is a rare but life-threatening complication of transcatheter aortic valve replacement (TAVR). Leaflet modification techniques have been developed to mitigate this risk; however, real-world evidence remains scarce. Objectives The aim of this study was to report procedural and 30-day outcomes of patients at high risk for CO undergoing leaflet modification. Methods LOFTER-TAVR (Leaflet mOdiFication Techniques to prEvent coRonary obstruction risk during Transcatheter Aortic Valve Replacement) was an international, multicenter registry of consecutive patients undergoing leaflet modification before TAVR (September 2019 to January 2026). Coprimary endpoints were leaflet modification–directed technical success and Valve Academic Research Consortium 3 (VARC-3) technical success. Secondary endpoints included in-hospital and 30-day outcomes. Results A total of 293 patients underwent leaflet modification, including 202 (68.9%) through a leaflet-splitting approach and 91 (31.1%) through an intraleaflet disruption approach. Overall, 139 of 293 (47.4%) treated valves were natives. Successful leaflet traversal occurred in 310 of 318 leaflets (97.5%; 95% CI: 94.9%-98.9%) and successful leaflet modification in 306 of 318 leaflets (96.2%; 95% CI: 93.3%-97.9%). Leaflet modification–directed technical success was achieved in 251 of 293 patients (85.7%; 95% CI: 81.0%-89.4%) and VARC-3 technical success in 254 of 293 patients (86.7%; 95% CI: 82.1%-90.3%). Notably, 91.1% (95% CI: 87.1%-94.0%) of patients underwent TAVR without CO events. Delayed CO occurred in 3 of 293 patients (1.0%; 95% CI: 0.3%-3.0%). The median follow-up duration was 100 days (Q1-Q3: 30-443 days). At 30 days, freedom from VARC-3 early safety was achieved in 181 of 293 patients (61.8%; 95% CI: 56.5%-67.6%). Conclusions Leaflet modification techniques demonstrated high technical feasibility across a broad anatomical spectrum but carried considerable early clinical risk. These findings support its role as an adjunctive strategy for selected patients undergoing TAVR, although in the context of careful preprocedural planning and a structured multidisciplinary approach. © 2026 American College of Cardiology Foundation.
Datos de la publicación
- ISSN/ISSNe:
- 1936-8798, 1876-7605
- Tipo:
- Article
- Páginas:
- 1639-1649
- PubMed:
- 42331413
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 3,595 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JACC-Cardiovascular Interventions ELSEVIER SCIENCE INC
Documentos
- No hay documentos
Filiaciones
Keywords
- Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Coronary Stenosis; Europe; Female; Heart Valve Prosthesis; Humans; Male; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Time Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome; hypertensive factor; aged; aortic dissection; aortic regurgitation; aortic stenosis; aortic valve leaflet modification; Article; clinical outcome; cohort analysis; coronary occlusion; feasibility study; female; follow up; heart left ventricle ejection fraction; heart perforation; heart tamponade; heart valve surgery; hemodynamics; high risk patient; human; intraleaflet disruption approach; leaflet splitting approach; major clinical study; male; multicenter study; multidisciplinary team; observational study; patient safety; patient selection; percutaneous coronary intervention; postoperative care; preoperative period; procedure registry; resuscitation; risk reduction; surgical anatomy; surgical approach; transcatheter aor
Cita
Occhipinti G,Laudani C,Jabri A,Pensotti F,Leone PP,Khokhar AA,Genereux P,Beneduce A,Wongpraparut N,Mangieri A,Serra V,Nombela L,SANCHEZ JS,Asmarats L,Teles RC,Chandavimol M,Romaguera R,Akodad M,Cuisset T,Tayal R,Algethami AR,Díaz JF,Laffond A,Martin P,Perez L,Ruiz V,Sarno G,Vázquez ME,Assafin M,García M,Ruberti A,Sanchis L,Freixa X,Maisano F,Buzzatti N,Giustino G,De Backer O,Latib A,Amat IJ,Villablanca PA,Regueiro A. Leaflet Modification to Mitigate Coronary Obstruction Risk During TAVR. JACC Cardiovasc. Interventions. 2026. 19. (12):p. 1639-1649. IF:12,700. (1).
Portal de investigación